Stockreport

Innovation Pharmaceuticals to Ship Brilacidin to U.S. Regional Biocontainment Laboratory for Research Against Coronavirus COVID-19

INNOVATION PHARMACEUTICAL  (IPIX) 
US:NASDAQ Investor Relations: ipharminc.com/press-release
PDF WAKEFIELD, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced toda [Read more]